Viemed completes share repurchase
By HME News Staff
Updated 8:33 AM CDT, Mon September 29, 2025
LAFAYETTE, La. - Viemed Healthcare has completed all repurchases authorized under its previously announced share repurchase program. "Completing this share repurchase program highlights both our confidence in Viemed's long-term outlook and our ongoing commitment to enhancing shareholder value,” said Casey Hoyt, Viemed's CEO. “With our strong balance sheet and ample liquidity driven by increasing free cash flow, we remain well positioned to continue investing in growth opportunities while returning capital to shareholders." On June 9, Viemed announced that its board of directors had authorized the repurchase of up to 1,976,441 common shares, representing about 5% of the total issued and outstanding shares at the time of authorization. The company has completed the repurchase and cancellation of all 1,976,441 common shares authorized under the program, for a total cost of approximately $13.2 million at a weighted average price of $6.69 per share, before taxes. The repurchases were executed through open market transactions in accordance with applicable securities laws.
Comments